Kwality Pharmaceuticals Other Announcement
Kwality Pharmaceuticals Ltd filed its shareholding pattern for the quarter ended September 30, 2026, as required by SEBI regulations.
ALFA Filings
Every announcement, straight from the exchange
Every Kwality Pharmaceuticals other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements
Kwality Pharmaceuticals Ltd filed its shareholding pattern for the quarter ended September 30, 2026, as required by SEBI regulations.
Kwality Pharmaceuticals Limited has announced the closure of its share transfer books from August 25, 2026, to August 31, 2026, for its 43rd Annual General Meeting.
Kwality Pharmaceuticals Ltd has filed its quarterly shareholding pattern under SEBI Regulation 31(1)(b) for the quarter ended June 30, 2026.
Kwality Pharmaceuticals submitted its Annual Secretarial Compliance Report for FY 2025-26. The auditor confirmed general compliance with SEBI regulations with no new penalties reported.
Kwality Pharmaceuticals Ltd submitted a compliance certificate under SEBI Regulation 74(5) for the quarter ended March 31, 2026. The Registrar and Share Transfer Agent, Bigshare Services, confirmed that securities received for dematerialization were processed, mutilated, and cancelled as per regulatory requirements.